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Doxorubicin-Induced Alopecia Is Associated
with Sebaceous Gland Degeneration
Silvia Selleri1,4, Holger Seltmann2,4, Silvia Gariboldi1, Yuri F. Shirai1, Andrea Balsari3,
Christos C. Zouboulis2,5 and Cristiano Rumio1,5
Alopecia, accompanied by skin dryness, is one of the distressing side effects often occurring in chemotherapy-
treated cancer patients. Little is known of the effects of chemotherapy on sebaceous glands, despite their
importance in hair follicle homeostasis. This study investigates sebaceous gland morphology and the response
of SZ95 sebaceous gland cell line to doxorubicin (DXR) treatment. The morphology of sebaceous glands during
intraperitoneal DXR treatment was investigated by optical and electron microscopy in a 7-day-old rat model and
further confirmed in an adult mouse model. Moreover, in vitro studies using the SZ95 sebaceous gland cell line
were performed to assess the response of sebocytes to DXR in terms of cell proliferation, apoptosis, and
necrosis. DXR treatment induced sebaceous gland regression and occasionally caused their complete
disappearance. This observed damage and disappearance preceded DXR-induced hair loss. In vitro experiments
using the SZ95 sebaceous gland cell line indicated that DXR treatment induced a differentiation process leading
to premature sebocytes apoptosis. Owing to the importance of the sebaceous gland in hair follicle homeostasis,
DXR-induced involution of this gland might be related to subsequent hair loss.
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INTRODUCTION
Sebaceous glands are flask-shaped, lobulated structures made
of packed, differentiated epithelial cells that often have a
foamy appearance in sections because of the lipid-rich
droplets that fill their cytoplasm. Small cells located at the
periphery of the gland are the germinative cells that
constantly replace differentiating sebocytes. These glands
exhibit holocrine secretion which empties into the upper
region of the hair follicle canal. This secretory product
contains exfoliated and disintegrated sebocytes that form an
oily or greasy product known as sebum, which was
historically thought to only serve as a softening and water-
proofing agent for the skin. Current knowledge now indicates
that the functions of the sebaceous gland are more complex.
The sebum is now known to play important roles in the three-
dimensional organization of skin surface lipids and the
integrity of the skin barrier (Stewart and Downing, 1991;
Pilgram et al., 2001; Fluhr et al., 2004), protect the skin
against oxidative stress (Thiele et al., 1999), and protect
keratinocytes against UVB irradiation (Marques et al., 2002).
Moreover, the sebum also exhibits innate antimicrobial
activity (Ge et al., 2003; Wille and Kydonieus, 2003; Georgel
et al., in press). Similarly, sebocytes express both pro- and
anti-inflammatory properties (Zouboulis et al., 1998; Bo¨hm
et al., 2002; Toyoda et al., 2002; Wro´bel et al., 2003), are
able to utilize cholesterol as a substrate for complete
steroidogenesis (Fritsch et al., 2001; Thiboutot et al., 2003),
present a regulatory program for neuropeptides (Zouboulis
et al., 2002), and selectively control the action of hormones
and xenobiotics on the skin (Akamatsu et al., 1992; Tsukada
et al., 2000). The importance of both the sebaceous gland
and sebum production in skin homeostasis is further
evidenced by the numerous skin disorders associated with
their aberrant activity, the most common of such disorders
being acne (Zouboulis et al., 2003; Zouboulis, 2004).
Normal development and function of the sebaceous gland
also appears to be very important for correct hair develop-
ment and cycling. The hair follicle is considered as a mini-
organ living in the context of the ‘‘pilo-sebaceous’’ unit,
which is composed of hair follicle, sebaceous gland, and
pilo-erector muscle (Montagna and Parakkal, 1974). Abnorm-
al sebaceous gland function within this context has been
clearly associated with hair loss in several animal models for
alopecia (Gates and Karasek, 1965; Gates et al., 1969;
Williams and Stenn, 1994; Stenn, 2001; Porter et al., 2002).
The administration of chemotherapeutics to humans
causes toxic side effects that also lead to hair loss. Such side
effects are frequently reversible but they still pose serious
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problems from a psychological point of view (Batchelor,
2001). Although patients often complain of dry skin
accompanying hair loss, studies on chemotherapy-induced
alopecia have to date been focused on the degeneration of
the deeper, transient portion of the hair follicle, the quality of
the hair, or on abnormalities in hair pigmentation (Paus et al.,
1994; Cece et al., 1996; Slominski et al., 1996; Ohnemus
et al., 2004; Sharov et al., 2004). A comprehensive study of
the chemotherapy-induced changes within the upper portion
of the pilo-sebaceous unit, in particular the sebaceous gland,
is still lacking.
We have thus evaluated the effect of doxorubicin (DXR)
treatment on the sebaceous gland in two different animal
models: a neonatal rat and an adult mouse, both previously
described for DXR-induced hair loss (Hussein et al., 1990;
Selleri et al., 2005). Regression of the sebaceous gland,
occasionally including its complete disappearance, was
observed in both models. Changes within the sebaceous
gland were found to precede DXR-induced hair loss.
Subsequent in vitro experiments, using the SZ95 sebaceous
gland cell line (Zouboulis et al., 1999), highlighted the
sensitivity of sebocytes to DXR, which induced differentiation
and premature apoptosis.
RESULTS
Morphological modifications of sebaceous glands induced by
DXR treatment
In order to study the fate of the sebaceous gland during
chemotherapy-induced alopecia, we investigated both the
structure and ultrastructure of the sebaceous gland during
DXR treatment in a newborn rat model and the structure of
the sebaceous gland in an adult mouse model after DXR
treatment. The degeneration of the sebaceous gland in both
animal models was compared to time-matched control
samples. In control samples, the gland maintained its
morphological features, irrespective of time point of analysis
(Figure 1).
In untreated control 7-day-old rats, optical microscopy
showed sebaceous glands with normal morphology and
functionality, evidenced by the presence of numerous
secretory vesicles in the cytoplasm and by a positive staining
for alkaline phosphatase (Figure 2a and b). The cells
appeared very metabolically active, with interspersed chro-
matin in the nucleus, detected by electron microscopy
(Figure 3a), which indicated transcriptional activity. Their
cytoplasm was full of secretory vesicles of varying
sizes, according to their state of maturation. Numerous
mitochondria, endoplasmic reticulum, and free ribosomes
were also all clearly visible. Lipid studies using Red Oil
staining were performed at different time points. This staining
a b c
Figure 1. Semithin sections of sebaceous glands from untreated rats. Control samples were collected at (a) T5, (b) T7, and (c) T10. The gland maintains the
same morphological features at every time point. Bar¼10 mm.
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Figure 2. Sebaceous gland regression accompanying hair loss induced by
DXR treatment. Semithin sections (left) and alkaline phosphatase reactions
(right) are shown. (a, b) Control, (c, d) Time point T5. The sebaceous gland is
markedly reduced in size but still present. (e, f) Time point T7. The sebaceous
gland appears very small, and the semithin section shows the presence of
clustered, condensed cells. (g, h) Time point T10. Animals show alopecia and
the rare hair follicles appear very small, shrunken, and damaged. Sebaceous
glands are undetectable. Bar¼ 10 mm.
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revealed that the sebocytes of control samples (Figure 4a)
were filled with small lipid droplets, indicating normal
glandular activity.
Five days after the start of DXR treatment, the sebaceous
glands were strongly reduced in size (Figure 2c and d) and the
cytoplasm of sebocytes appeared depleted of secretory
granules (Figure 3b). Apparently, under a conventional light
microscopy, the hair follicles failed to show any significant
signs of suffering. However, an increase in the number of
apoptotic cells in the connective tissue sheath (CTS) and
sporadically in the matrix cells was observed by high-
resolution light microscopy and by electron microscopy
(data not shown), thus confirming previous observations
(Selleri et al., 2004). After 7 days, an almost complete
regression of the sebaceous glands was observed in treated
animals. At this stage, visible by optical microscopy and
alkaline phosphatase staining, a significantly reduced number
of cells were filled with excretory granules and a condensa-
tion of the cytoplasm was visible in the majority of sebocytes,
(Figure 2e and f). Red Oil staining performed on these
samples showed a reduction in intensity with respect to the
control, demonstrating a reduced amount of lipid within the
sebocytes (Figure 4b and c). Electron microscopy revealed
that these cells, which were reduced in size, showed an
abnormally enlarged rough endoplasmic reticulum and much
smaller vesicles. Mitochondria were conserved, thus suggest-
ing that the sebocytes had not completely lost their metabolic
function. An abnormal accumulation of collagen fibers was
also noted among treated sebocytes (Figure 3c). In the hair
follicle, the initial phases of follicular structure degeneration,
the first signs of oncosis in ORS cells, and apoptosis in CTS
fibroblasts were now all detected (data not shown), as also
previously reported (Selleri et al., 2004).
Ten days after the start of DXR treatment, the regression of
sebaceous glands was visible by optical microscopy. The
almost complete disappearance of the sebaceous glands was
further evidenced by alkaline phosphatase staining (Figure 2g
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Figure 3. Electron microscopy of sebaceous glands at different time points.
(a) Control, (b, c, d) 5, 7, 10 days, respectively, after the start of treatment. In
(d) the condensed material obstructing the pilary canal is sebum. Bar¼ 1 mm.
a b
dc
Figure 4. Red Oil staining of rat sebaceous glands showing a progressive
regression. (a) Control animal. (b, c, d) 5, 7, 10 days, respectively, after the
start of DXR treatment. Bar¼10 mm.
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Figure 5. Measurement of sebaceous gland area in control and DXR-treated
animals. Value means and standard deviation are shown for T5, T7, and T10
days after the start of treatment.
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Figure 6. Detection of apoptosis in rat sebaceous glands. The percentage
of apoptotic cells was evaluated by the TUNEL assay in both untreated
and DXR-treated samples at T5 and T7. The total number of cells, stained
with 4,6-diamidino-2-phenylindole was compared to the cells positive for
TUNEL staining.
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and h). At this stage, Red Oil staining barely detected what
remained of the sebaceous glands, probably also because of a
further reduction of their lipid content (Figure 4d). Electron
microscopy also failed to detect sebaceous glands. An
abnormal accumulation of a condensed lipid-like material
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Figure 7. The sebaceous glands of C57BL/6 mice 7 days after DXR
treatment. (a) Control animal. (b) DXR-treated animal. Bar¼10 mm.
(c) Measurement of the sebaceous gland area of both control and
DXR-treated animals. Value means and standard deviation are shown.
5.000
4.500
4.000
3.500
3.000
2.500
2.000
1.500
1.000
0.500
0.000
Ar
ea
 (
2 )
Ar
ea
 (
2 )
20.000
18.000
16.000
14.000
12.000
10.000
8.000
6.000
4.000
2.000
0.000
Anagen Catagen
Anagen Catagen
Mean area (m2)
Standard deviation
Mean area (m2)
Standard deviation
Mouse anagen stage
Rat anagen stage
Mouse catagen stage
Rat catagen stage
3.56 3.78
0.961.03
16.28 15.89
1.070.56
a
b
Figure 8. Measurement of sebaceous gland area in C57BL/6 mice (a) and in
rats (b) during anagen and catagen stage of the hair follicle. Value means
and standard deviations are shown.
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Figure 9. SZ95 sebocyte cultures treated with different DXR concentrations (upper panel). In the lower panel, the respective volumes of the cytoplasm and
nucleus as well as the cytoplasm/nuclear ratio are presented. Already at 107 M DXR an increased cytoplasm volume can be observed. This further increases in a
dose-dependent manner. The nuclear volume is not affected by DXR at the concentrations tested. ***Po0.001.
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was the only object present in the follicular canal (Figure 3d).
In parallel, hair degeneration was almost complete, and
treated animals started to show baldness within the occipital
region.
To quantify rat sebaceous gland regression, sebaceous
gland areas were measured at the different time points of
observation. Value means are presented in Figure 5. A
dramatic reduction of gland surface area, starting from 5 days
after the start of DXR treatment, was observed. The surface of
the gland was almost completely undetectable 10 days after
DXR treatment.
TUNEL assays on samples derived from both treated and
control rats, killed at 5 and 7 days after DXR treatment, were
performed in order to assess whether the reduction of
sebaceous gland size was related to sebocyte apoptosis.
Immunofluorescence analysis of untreated control animals
indicated that 25 and 28% of sebocytes, at days 5 and 7
respectively, were apoptotic. These values are consistent with
the physiological amount of sebocytes undergoing holocrine
secretion. In contrast, a statistically significant (Po0.0001)
increase in apoptosis was observed in the sebocytes of DXR-
treated animals. In these DXR-treated animals, 47 and 66% of
sebocytes were apoptotic, at days 5 and 7, respectively
(Figure 6).
We further evaluated the involution of the sebaceous
gland using the adult mouse model. Analyses were performed
7 days after DXR treatment, when DXR-induced alopecia was
evident. As previously observed in the newborn rat animal
model, significant reductions of the sebaceous glands were
clearly visible (Figure 7a and b). Statistical analysis of the
sebaceous gland surface area of treated and untreated
animals again confirmed the data previously observed in
the newborn rat model (Figure 7c).
Evaluation of sebaceous gland morphology and size in
untreated animals in the anagen and catagen stage revealed
no difference among their glands, which always presented
the same features during the hair cycle, in both the rat and the
mouse model (Figure 8).
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Figure 10. In vitro experiments on SZ95 sebocytes depicting (a) cell numbers, (b) caspase-3/7 activity as marker of apoptosis, and (c) lactate dehydrogenase
(LDH) release as marker of dead cells. A DXR dose-dependent reduction of cell number is associated with marked apoptosis and cell death, where apoptosis
preceded cell death. Asterisks indicate statistical significance, ***Po0.001.
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Figure 11. Proliferation of SZ95 sebocyte cultures treated with different DXR concentrations. DXR concentrations greater than 106 M were 100% toxic after
only 2 days of treatment. In contrast, a DXR dose of 107 M was subtoxic and dependent on the duration of treatment. *Po0.05, **Po0.01, ***Po0.001.
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DXR effect on SZ95 sebaceous gland cells
Terminal sebocyte differentiation, consisting of an increased
cell volume, the accumulation of lipid droplets within the
cytoplasm and nuclear degradation, has previously been
shown to precede the physiological bursting of the cells and
subsequent SZ95 cell death (Zouboulis et al., 1994).
However, premature sebocyte differentiation and apoptosis
has also been described in SZ95 sebocytes treated with
staurosporine, in which the sebocytes proceed to apoptosis
without entering terminal differentiation marked by en-
hanced lipid synthesis (Wro´bel et al., 2003).
Treatment of SZ95 sebocytes with different concentrations
of DXR induced a dose-dependent increase of cytoplasm
volume, which was first visible at a DXR concentration of
107 M. This increase in cytoplasmic volume, indicating
sebocyte differentiation (Figure 9), preceded the reduction of
SZ95 sebocyte numbers (observed at a DXR concentration of
106 M; Figure 10a). Treatment with 107 M DXR induced a
time-dependent inhibition of SZ95 sebocyte proliferation,
assessed by the 4-methylumbelliferyl heptanoate fluores-
cence assay. Only 10-fold increase in DXR (106 M) caused a
100% inhibition of cell growth after 96 hours incubation
(Figure 11). At both the high, yet non-toxic (107 M) and toxic
(106 M) DXR concentrations, a significant enhancement of
caspase-3/7 activity was detected (Figure 10b), indicating an
enhanced rate of sebocyte apoptosis. However, nontoxic
concentrations of DXR (107 M) unessentially affected lipid
synthesis, shortly before reaching the cytotoxic concentration
(data not shown). This indicated that the observed increase in
apoptosis was occurring prematurely, that is, before sebo-
cytes entered terminal differentiation with increased lipid
synthesis.
As shown in Figure 12, TUNEL assay on SZ95 sebocyte
cell line confirmed the data on apoptosis previously detected
by caspase activity: whereas control cells (Figure 12a) show
no positivity for TUNEL assay, the percentage of positive
sebocytes increases with increasing DXR concentrations
(Figure 12b and c), so that at DXR 105 M most of the cells
are apoptotic (Figure 12d). The graph and the table (Figure
12e) clearly show these results.
At a 106 M dose of DXR, cells began to both sponta-
neously detach from the culture dish and lose their flat
epithelial morphology (Figure 9). At DXR concentrations
above 2106 M, a significant increase in lactate dehydro-
genase was measured, indicating sebocyte necrosis (Figure
10c).
By considering DXR at a concentration of 106 M as the
critical dose over which major toxic effects were observed,
we examined whether the inhibition of cell growth was due
to cell cycle arrest. We analyzed the cell cycle at this dose of
DXR by assessing the distribution of cellular DNA content by
flow cytometry. A decreased G0–G1 peak, together with an
accumulation of SZ95 sebocytes at the G2–M and S phases,
was detected (Figure 13). This phenomenon is known to
precede apoptosis (Wro´bel et al., 2003).
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Figure 12. Detection of apoptosis on SZ95 sebocytes cell line as assessed by
TUNEL assay. (a) Untreated cells; (b) treated cells with 107 M, (c) 106 M, and
(d) 105 M DXR. (e) The graph and the table indicate the mean values and
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Figure 13. Cell cycle analysis of SZ95 sebocytes either untreated or treated
with DXR at a concentration of 106 M, with respect to untreated controls, in
the G2–M and S phases of the cell cycle was observed. This suggested that
cells were entering apoptosis.
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DISCUSSION
We observed the complete disruption of the sebaceous
glands, preceding hair loss, in our animal models of
chemotherapy-induced alopecia. This phenomenon ap-
peared to accompany baldness, with a progressive and rapid
reduction in the number and volume of lipid droplets within
sebocytes and in a condensation of holocrine lipid secretion
in the follicular canal. Five days after starting DXR treatment,
sebaceous glands were still present, yet indicated a slow cell
death which was incompatible with necrosis. Accordingly,
data obtained by the TUNEL assay indicated a 50% increase
in sebocyte apoptosis in DXR-treated animals with respect to
the physiological level of apoptosis detected in control
samples.
As holocrine secretion can be considered a form of
apoptosis, it is quite usual to observe relatively high
physiological levels of apoptosis within the sebaceous gland.
The further increased levels of apoptosis observed in DXR-
treated animals cannot be considered linked to increases in
sebum production, but rather, must be associated with
nonphysiological increases in sebocyte cell death. This was
clearly demonstrated by Red Oil staining, which revealed the
presence of lipids that only showed a faint staining in DXR-
treated samples with respect to the control. This suggested
that holocrine secretion of the sebaceous gland is reduced
after DXR treatment, whereas apoptosis, leading to the
sebocyte death, is increased.
As DXR induces premature catagen, we also evaluated the
morphology and size of sebaceous glands during normal hair
cycle, to exclude that the observed reduction in size of the
gland was usually present during the spontaneous degenera-
tion stage (catagen). Our data, in both the rat and the mouse
model, indicate that during normal hair cycle, from anagen to
catagen stage, the sebaceous gland does not show any
reduction in size and maintains the same morphological
features, as previously described (Han et al., 2005).
We also performed in vitro studies on the SZ95 sebocyte
cell line. This cell line is a widely used immortalized human
sebaceous gland cell line, which retains the major character-
istics of normal human sebocytes, such as differentiation with
increases in both cell volume and lipid synthesis followed by
apoptosis. These cells also express characteristic origin- and
function-specific proteins of human sebaceous glands and
respond correctly to androgens and retinoids (Zouboulis
et al., 1999; Wro´bel et al., 2003).
Following the DXR treatment of SZ95 sebocytes, increases
in both caspase activity and TUNEL positivity and cells within
the G2–M and S phases of the cell cycle were observed. This
finding indicated that apoptosis preceded physiological cell
bursting and release of secretory granules (Wro´bel et al.,
2003). Induction of apoptosis is a known typical effect of
many anticancer drugs (Kim et al., 2002; Kaufmann and
Vaux, 2003). On the other hand, sebocytes in vivo undergo
apoptosis after terminal differentiation and during holocrine
secretion (Tamada et al., 1994; Kishimoto et al., 1999). We
can thus consider that, as already shown for staurosporine
(Wro´bel et al., 2003), DXR accelerates this process by
inducing apoptosis before sebocytes enter the terminal
differentiation process. This is confirmed by the observed
accumulation of sebum in the pilary canal, up to the level
that sustains the regeneration of the sebaceous gland from its
germinative layer. Considering the role of the sebaceous
gland in hair follicle homeostasis, the direct action of DXR on
the sebaceous gland can be associated with the occurring
alopecia.
It is noteworthy that gland degeneration precedes hair loss.
The involution of the sebaceous gland is significant at 5 days
after DXR treatment. In contrast, only some rare apoptotic
phenomena are present within the hair follicle at this time
point, which starts to visibly degenerate only at day 7 after
DXR treatment.
Lipid secretion from sebaceous glands seems to be
involved in the correct protrusion of the hair shaft, by
permitting the dissociation of the fiber from the inner root
sheath. Previous in vitro studies have shown that in follicles
deprived of their sebaceous gland portion, the shaft grows out
with the inner root sheath. The mutant ‘‘asebia’’ mouse
exhibits hair loss and scarring alopecia associated with
markedly hypoplastic sebaceous glands (Stenn, 2001). Data
reported on this animal model indicate that the absence of
sebaceous gland function leads to follicle destruction. Also
the mutant ‘‘defolliculated’’ mouse shows abnormal differ-
entiation of the sebaceous gland, with the sebocytes
producing little or no sebum and undergoing abnormal
cornification that accompanies an irregular hair follicle
formation (Porter et al., 2002).
To our knowledge, this is the first report of sebaceous
gland damage during chemotherapy-induced alopecia.
Degeneration of the sebaceous gland after DXR treatment
was observed in both newborn rats and in adult mice. This
indicates that the observed degeneration is not restricted to a
single animal model. It may be possible that this strong
sebaceous gland degeneration, which was not observed in
cyclofosfamide-induced alopecia (Ohnemus et al., 2004;
Sharov et al., 2004), is specifically related to DXR treatment.
Damage to the sebaceous gland can explain the ‘‘dry skin’’
complaints frequently submitted by patients undergoing
anticancer therapy. Considering the importance of the
sebaceous gland in allowing correct hair cycle progression,
our findings suggest the possible involvement of the seba-
ceous gland in chemotherapy-induced hair loss. Pharmaco-
logical studies targeting the prevention of premature apop-
tosis and sebaceous gland damage may be proven useful in
controlling hair loss and skin xerosis in DXR-treated patients
suffering from alopecia.
MATERIALS AND METHODS
In vivo experiments
Animals. For the rat model of chemotherapy-induced alopecia, we
adopted the method described by Hussein et al. (1990) with only a
few modifications: DXR 3 mg/kg/day for 4 subsequent days was
injected intraperitoneally into 7-day-old rats with hair follicles in the
final stages of postnatal hair follicle morphogenesis. Mild or severe
alopecia, within the region of the head and neck, was observed in
approximately 80% of the injected rats at about 10 days after the
start of DXR administration. Skin samples were obtained daily during
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DXR treatment from three treated and one control rat until alopecia
was detected.
For studies on adult mice, we adopted the method by Selleri et al.
(2005). The dorsal skin of 7-week-old C57BL/6 mice was treated
with a mixture of wax-rosin. The removal of this mixture allowed for
the complete removal of all the hair shafts. The homogeneous pink
color of the skin revealed the telogen phase of the hairs. Depilation
at this hair stage induced the development of a synchronous anagen
stage. Mice received a single intraperitoneal dose of DXR (15 mg/kg)
9 days after depilation when synchronized hair follicles were in the
anagen VI phase. Normal regrowth of hairs was observed in
untreated control animals while the newly formed pelage was lost
in DXR-treated animals. Skin samples were collected 7 days after
DXR treatment, when the fur of untreated control animals had
completely regrown and alopecia was clearly evident in DXR-
treated mice.
For both the rat and the mouse model, we also collected samples
from untreated animals in the anagen stage and in the spontaneous
degeneration stage (catagen), to observe whether any change in
sebaceous gland morphology was present.
Experimental protocols were approved by the Ethics Committee
for Animal Experimentation of the Istituto Nazionale Tumori of
Milan, according to guidelines of United Kingdom Co-ordinating
Committee on Cancer Research for animal welfare in experimental
neoplasia (1998).
Optical microscopy. Rat skin samples were snap frozen in liquid
N2 vapor immediately after the performance of the biopsy and
included in OCT mounting medium. Cryostat sections (7 mm
thickness) were obtained and stored at 301C until use.
C57BL/6 mice skin samples were collected from the back of mice
and immediately fixed in 10% buffered formalin for 4 hours at 41C
and embedded in paraffin. Paraffin specimens were sectioned at
5mm and collected on silanized slides, deparaffinized, rehydrated,
stained with hematoxylin and eosin and mounted in Entellans.
Electron microscopy. Rat skin samples (2 4 mm) were fixed in
3% glutaraldehyde in 0.1 M phosphate buffer (pH 7.4) for 3 hours at
41C, washed in 0.1 M phosphate buffer, postfixed in 1% osmium
tetroxide in 0.1 M phosphate buffer, dehydrated through an ascend-
ing series of ethanol and embedded in araldite. Ultrathin sections
were cut on a diamond knife, with a Reichter Ultracut R
ultramicrotome (Leica, Wien, Austria), stained with uranyl acetate
and lead citrate, and then observed with a Jeol CX100 transmission
electron microscope (Jeol, Tokyo, Japan). Semithin sections were
stained with toluidine blue for observation with optical microscope.
Red Oil staining. Cryostat sections of rat skin (7 mm thickness) were
obtained and stored at 301C until use. At the moment of use,
sections were washed in distilled water and stained for 10 minutes in
Red Oil O solution (saturated solution of Red Oil in isopropylic
alcohol). After washing in distilled water, slides were counterstained
with hematoxylin to obtain nuclear staining, washed again in water,
and mounted in glycerinated gelatin.
Alkaline phosphatase staining. Specific staining was performed
on cryostat sections of rat skin using the BCIP/NBT liquid substrate
system (Sigma, Deisenhofen, Germany). Briefly, sections were dried
at room temperature, fixed with cold acetone (301C) for 3 minutes,
washed with physiological solution, incubated with the reagent
(1–2 minutes) at room temperature in the dark, washed with
bidistilled water and mounted with Mowiol (Calbiochem, Bad
Soden, Germany). Cryostat sections stained for alkaline phosphatase
activity, sections stained with Red Oil, and semithin sections stained
with toluidine blue were all observed with a Nikon Eclipse 600
microscope equipped with a digital Nikon DXM 1200 camera.
Detection of apoptosis. DNA fragmentation was assessed by
TUNEL (In situ cell detection kit; Roche Diagnostic GmbH,
Penzberg, Germany), according to the manufacturer’s instructions.
Briefly, cryostat sections of rat skin were dried at room temperature,
fixed for 20 minutes with 4% paraformaldehyde in phosphate-
buffered saline (PBS) (pH 7.4) and washed in PBS. After a 10-minute
incubation in blocking solution (3% H2O2 in methanol), slides were
rinsed with PBS and subsequently incubated for 2 minutes on ice in a
permeabilization solution (0.1% Triton X-100, 0.1% sodium citrate).
After rinsing with PBS, sections were incubated for 1 hour at 371C
with the TUNEL Reaction Mixture (fluoresceinate), washed with PBS
and mounted with Mowiol after the nuclei had been labelled with
4,6-diamidino-2-phenylindole staining.
Slides were analyzed by fluorescence microscopy using a Nikon
Eclipse 600 equipped with selective excitation filters suitable for
analyzing fluorescein labelled fragmented DNA and the 4,6-
diamidino-2-phenylindole counterstain. Three independent obser-
vers randomly selected different optical fields containing sebaceous
glands in order to determine the percentage of positive staining
(apoptotic sebocytes).
Light microscopy morphometric analysis of the sebaceous
glands. We considered about 40 pilo-sebaceous units from treated
and untreated animals, from both rats and mice, at different time
points. The sebaceous gland section area, from longitudinally
sectioned hair follicles, was measured. Digital images of the samples
were imported into the LaserPix image analysis program (version
4.0, Bio-Rad Laboratories (Segrate, Italy), sebaceous glands were
manually outlined and section areas automatically measured. The
software was previously calibrated using a micrometer object
photographed at the same enlargement used to collect the images
of the sebaceous glands.
In vitro experiments
Cell culture. SZ95 sebocytes (Zouboulis et al., 1999), from passage
26, were maintained in Sebomeds culture medium (Biochrom,
Berlin, Germany) supplemented with 10% fetal calf serum, 5 ng/ml
human epidermal growth factor, 1 mM CaCl2, and 50 mg/ml
gentamicin (all from Sigma), in a humidified atmosphere containing
5% CO2 at 371C. Subconfluent cell cultures were harvested with
Accutase (PAA, Co¨lbe, Germany) and seeded in 96-well culture
plates at a density of 2 104 cells/well (approximately 60%
confluence) in complete culture medium. All evaluations were
performed 24 hours after seeding, in which cultures ranged between
80 and 100% confluence. Experiments were performed in triplicate,
with 10 wells evaluated for each data point in each experiment.
DXR treatment. DXR was dissolved in dimethyl sulfoxide (Sigma)
to give final concentrations between 109 and 105 M. The final
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concentration of dimethyl sulfoxide in the medium, either with or
without DXR, was 0.1%.
Cell number assessment. Cell numbers were measured indirectly
by the fluorescein diacetate assay (Sigma) as previously described
(Larsson and Nygren, 1989). Briefly, cells were stained with the
fluorescent dye fluorescein diacetate. Fluorescence is dependent on
cellular hydrolysis of the non-fluorescent substrate into its fluor-
escent product. Fluorescence signals from the two dyes were
compared to give the amount of intact and viable cells in the culture.
Cell proliferation. Adherent SZ95 sebocytes (1,000 cells/well in
96-well plates) were washed with PBS and treated with DXR at the
above-mentioned concentrations. Cell proliferation was assessed by
the 4-methylumbelliferyl heptanoate assay and measured automati-
cally, after 48 and 96 hours, as previously described (Zouboulis
et al., 1991). Culture medium was renewed on the second day of
growth. Briefly, on the day of proliferation evaluation, the medium
was removed, the cells were washed twice in PBS and 100 ml of a
100mg/ml 4-methylumbelliferyl heptanoate fluorescence solution in
PBS was added to each well. The plates were subsequently
incubated at 371C for 30 minutes. The released fluorescence,
representative for cell number, was read in a Molecular Devices
SPECTRAmax Gemini spectrofluometer using 355 nm excitation and
460 nm emission filters.
Detection of apoptosis. Caspase-3/7 activity, as a measure of cell
apoptosis, was analyzed using a high throughput screening
commercial assay (Apo-ONE Homogenous Caspase-3/7 Assay,
Promega, Madison, WI) according to the manufacturer’s instructions.
Briefly, upon cleavage on the C-terminal side of the aspartate residue
in the DEVD peptide substrate sequence by caspase-3/7 enzymes,
the rhodamine 110 becomes fluorescent. After DXR treatment of
cells for 24 hours and incubation at 371C for 2 hours, the bifunctional
cell lysis/activity buffer and the profluorescent caspase-3/7 con-
sensus substrate bis-(N-CBZ-L-aspartyl-L-glutamyl-L-valyl-aspartic
acid amide) rhodamine 110 (Z-DEVD-R110) provided were added
to the cells. The solution was then excited at a wavelength of 498 nm
and read at the maximum emission of 521 nm in a Molecular
Devices SPECTRA Max Gemini spectrofluorometer. The amount of
fluorescent product generated was representative of the amount of
active caspase-3/7 present in the sample.
Sebocytes apoptosis was confirmed performing TUNEL assay
(DeadEnd Colorimetric TUNEL System, Promega Corporation,
Madison, WI) on cells treated with the above-mentioned DXR
concentrations for 24 hours, according to the manufacturer’s
instructions.
Detection of cell necrosis. Cell necrosis was determined using a
colorimetric assay for the quantification of cell death and cell lysis
(Cytotoxicity detection kit; Boehringer-Mannheim, Mannheim,
Germany). This assay, as previously described (Wro´bel et al.,
2003), is based on the release of lactate dehydrogenase from the
cytoplasm of damaged cells into the supernatant.
Determination of cellular and nuclear size. Cellular and
nuclear size of SZ95 sebocyte suspensions, harvested after cell
dissociation with Accutase, was determined with the help of a cell
counter with adequate software (Casy 1; Scha¨rfe Systems, Reutlin-
gen, Germany).
Cell cycle analysis. Cell cycle analysis was performed by two-
color FACS on a Becton-Dickinson (Heidelberg, Germany) flow
cytometer, FACS-Calibur. SZ95 sebocytes (5 105) were dissociated
from culture dishes with Accutase, pelleted and resuspended in
400ml citrate buffer in order to denature DNA. The cells were
subsequently labelled as previously described (Dolbeare et al.,
1983), with BrdU, binding single-stranded DNA and propidium
iodide, which binds intact DNA. The BrdU was detected using a
fluorescein-conjugated BrdU antibody. Both fluoresceins were
exited at 488 nm with an argon laser. The fluorescein emission of
BrdU fluorescein was detected at 530 nm, whereas that of propidium
iodide was detected at 585 nm. Overlapping emissions were
electronically compensated. Data were evaluated, with respect to
a nonspecific isotypic-matched antibody control, using CELLQuest
software (Becton-Dickinson).
Presentation of the data and statistical analysis. All data are
presented as mean values7standard deviation. Three or more
repeats were performed for each assay. Statistical significance of
the data was evaluated by the two-tailed Student’s t-test. Mean
differences were considered to be significant at Po0.05.
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